IDXX - IDEXX Laboratories, Inc.
| Previous Close | 230.38 |
| Open | 223.54 |
| Bid | 208.00 x 1100 |
| Ask | 239.00 x 900 |
| Day's Range | 223.54 - 237.05 |
| 52 Week Range | 168.65 - 296.25 |
| Volume | 857,952 |
| Avg. Volume | 682,124 |
| Market Cap | 19.775B |
| Beta (5Y Monthly) | 0.81 |
| PE Ratio (TTM) | 47.39 |
| EPS (TTM) | 4.89 |
| Earnings Date | Apr 28, 2020 - May 03, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 280.60 |
- MarketWatch
Second dog tests positive for coronavirus as owners warned not to abandon pets
A German shepherd pet dog in Hong Kong has repeatedly tested positive for the Covid-19 virus after its owner was confirmed as being infected, authorities said.
- MarketWatch
Hong Kong Pet dog that tested for coronavirus dies after returning from quarantine virus-free
The Hong Kong pet dog that was tested for coronavirus has died two days after being released from a government quarantine having been declared virus-free.
- Zacks
Here's Why You Should Hold Onto Baxter (BAX) Stock for Now
Baxter (BAX) issues strong guidance for the first quarter of 2020.
- Zacks
HealthEquity (HQY) Q4 Earnings and Revenues Top Estimates
HealthEquity's (HQY) fiscal fourth-quarter earnings benefit from higher revenues and solid performing Service, Custodial and Interchange segments.
- Insider Monkey
Hedge Funds Have Never Been More Bullish On IDEXX Laboratories, Inc. (IDXX)
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
- Zacks
Here's Why You Should Hold Onto Varian Medical Stock Now
Varian Medical (VAR) gains from solid prospects of its core Oncology Systems unit.
- Simply Wall St.
Here's Why I Think IDEXX Laboratories (NASDAQ:IDXX) Is An Interesting Stock
It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...
- Zacks
Here's Why You Should Buy Cooper Companies (COO) Stock Now
Cooper Companies (COO) lifts adjusted earnings per share view for fiscal 2020.
CNW GroupLeading Veterinary Diagnostic Company Sees No COVID-19 Cases in Pets
Leading Veterinary Diagnostic Company Sees No COVID-19 Cases in Pets
- Zacks
Cooper Companies (COO) Misses on Q1 Earnings, Lifts View
Cooper Companies (COO) gains from core CVI segment in fiscal Q1.
- Zacks
5 Must-Buy S&P 500 Large-Cap Growth Stocks at a Discount
As a result of regular market fluctuations, several growth stocks have become ultra-cheap at present, some of which have strong growth potential.
- GuruFocus.com
IDEXX Laboratories: A Widening Moat and a Massive Runway Ahead
One of our top picks to capitalize on the booming pet economy Continue reading...
- Zacks
Allscripts (MDRX) Q4 Earnings and Revenues Miss Estimates
Allscripts (MDRX) fourth-quarter results gain from higher revenues along with growth in bookings. Contraction in both gross and operating margins remains a woe.
- Zacks
Veeva Systems (VEEV) Q4 Earnings and Revenues Beat Estimates
Veeva Systems (VEEV) gains from segmental strength in the fiscal fourth quarter.
- Zacks
Here's Why You Should Hold Avanos Medical (AVNS) Stock Now
Avanos (AVNS) gains from solid fourth-quarter show despite headwinds in the Acute Pain business.
- Zacks
Glaukos (GKOS) Q4 Earnings and Revenues Surpass Estimates
Glaukos (GKOS) fourth-quarter results benefit from revenue growth. However, rise in operating expenses remains a concern.
- Zacks
DENTSPLY SIRONA (XRAY) Q4 Earnings Lag Estimates, Sales Rise
DENTSPLY SIRONA (XRAY) gains from the Technologies & Equipment arm in Q4.
- Zacks
Why Is Idexx (IDXX) Down 10.3% Since Last Earnings Report?
Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks
Avanos (AVNS) Earnings and Revenues Beat Estimates in Q4
Avanos (AVNS) gains from segmental contributions in Q4.
- Zacks
OPKO Health (OPK) Q4 Loss Narrower Than Estimates, Sales Up
OPKO (OPK) gains from increase in RAYALDEE prescriptions.
- Zacks
Nevro (NVRO) Q4 Loss Narrower Than Expected, Revenues Up Y/Y
Nevro (NVRO) sees strong segmental contributions in Q4.
- Zacks
Inogen's (INGN) Q4 Earnings Miss, Revenues Top Estimates
Inogen (INGN) sees segmental softness in the fourth quarter.
- Zacks
Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year?
Is (IDXX) Outperforming Other Medical Stocks This Year?
- GuruFocus.com
Ron Baron Cuts CoStar, Vail Resorts
Guru's largest sales of the 4th quarter Continue reading...
- Zacks
PRA Health (PRAH) Q4 Earnings and Revenues Beat Estimates
Solid Clinical Research revenues drove PRA Health's (PRAH) Q4 results.
